T. Rowe Price Associates’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.01M | Buy |
|
|||||
|
2025
Q2 | $879K | Buy |
|
|||||
|
2025
Q1 | $745K | Buy |
|
|||||
|
2024
Q4 | $826K | Sell |
|
|||||
|
2024
Q3 | $1.24M | Buy |
|
|||||
|
2024
Q2 | $1.34M | Sell |
|
|||||
|
2024
Q1 | $2M | Sell |
|
|||||
|
2023
Q4 | $1.94M | Sell |
|
|||||
|
2023
Q3 | $2.39M | Sell |
|
|||||
|
2023
Q2 | $3.21M | Buy |
|
|||||
|
2023
Q1 | $2.56M | Sell |
|
|||||
|
2022
Q4 | $2.36M | Sell |
|
|||||
|
2022
Q3 | $20.1M | Sell |
|
|||||
|
2022
Q2 | $136M | Buy |
|
|||||
|
2022
Q1 | $124M | Buy |
|
|||||
|
2021
Q4 | $118M | Sell |
|
|||||
|
2021
Q3 | $142M | Sell |
|
|||||
|
2021
Q2 | $149M | Sell |
|
|||||
|
2021
Q1 | $135M | Sell |
|
|||||
|
2020
Q4 | $158M | Buy |
|
|||||
|
2020
Q3 | $112M | Buy |
|
|||||
|
2020
Q2 | $102M | Buy |
|
|||||
|
2020
Q1 | $82.7M | Buy |
|
|||||
|
2019
Q4 | $114M | Buy |
|
|||||
|
2019
Q3 | $128M | Sell |
|
|||||
|
2019
Q2 | $129M | Buy |
|
|||||
|
2019
Q1 | $111M | Sell |
|
|||||
|
2018
Q4 | $109M | Sell |
|
|||||
|
2018
Q3 | $133M | Sell |
|
|||||
|
2018
Q2 | $121M | Buy |
|
|||||
|
2018
Q1 | $102M | Buy |
|
|||||
|
2017
Q4 | $88.3M | Sell |
|
|||||
|
2017
Q3 | $76.1M | Buy |
|
|||||
|
2017
Q2 | $73.3M | Buy |
|
|||||
|
2017
Q1 | $76.2M | Buy |
|
|||||
|
2016
Q4 | $71.7M | Buy |
|
|||||
|
2016
Q3 | $19.4M | Buy |
|
|||||
|
2016
Q2 | $16.9M | Buy |
|
|||||
|
2016
Q1 | $13.4M | Buy |
|
|||||
|
2015
Q4 | $13.9M | Buy |
|
|||||
|
2015
Q3 | $10.2M | Buy |
|
|||||
|
2015
Q2 | $7.55M | Buy |
|
|||||
|
2015
Q1 | $304K | Hold |
|
|||||
|
2014
Q4 | $269K | Buy |
|